TrialBMC cancer2016

Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial.

Peter Reichardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.